The implementation and compliance of transaction reporting and transparency obligations presents investment firms with some difficult choices. Is it better for the company to outsource transaction reporting, either through transmission or through an Approved Reporting Mechanism (ARM), or is it better to share sensitive information as little as possible and send the transaction report to the regulator itself? And what exactly about transparency obligations? Is it perhaps wise to stop trading in OTC derivatives altogether to avoid transparency obligations entirely, or are OTC derivatives an indispensable part of the business? The purpose of this white paper is to gain more insight into how they deal with these difficult choices and what approach they have chosen by conducting interviews with various financial players on the buy-side of the industry. All information obtained has been anonymously incorporated into this white paper.

Download or read the white paper here: Implementation and compliance of transaction reporting and transparency requirements under MIFID II